Evommune, Inc.
EVMN
$18.41
-$1.82-9.00%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -64.76M | -78.58M | -66.81M | -- | -- |
| Total Depreciation and Amortization | 1.44M | 1.39M | 1.29M | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8.38M | 307.00K | -98.00K | -- | -- |
| Change in Net Operating Assets | -23.15M | -383.00K | 7.42M | -- | -- |
| Cash from Operations | -94.85M | -77.26M | -58.20M | -- | -- |
| Capital Expenditure | 0.00 | -18.00K | -88.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 7.83M | -123.00K | -3.91M | -- | -- |
| Cash from Investing | 7.83M | -141.00K | -3.99M | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -562.00K | -515.00K | -423.00K | -- | -- |
| Issuance of Common Stock | 17.00K | 13.00K | 13.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 115.06M | 49.83M | 49.83M | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -736.00K | -- | -- | -- | -- |
| Cash from Financing | 113.78M | 49.33M | 49.42M | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 26.76M | -28.08M | -12.77M | -- | -- |